Literature DB >> 27222020

Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Kazuhiro Kitajima1, Hiroshi Doi2, Kozo Kuribayashi3.   

Abstract

Positron emission tomography/computed tomography (PET/CT) integrated with 2-[(18)F]fluoro-2-deoxy-D-glucose ((18)F-FDG) has emerged as a powerful tool for combined metabolic and anatomic evaluations in clinical oncologic imaging. This review discusses the utility of (18)F-FDG PET/CT as a tool to manage patients with malignant pleural mesothelioma. We discuss different stages of patient management in malignant pleural mesothelioma, including diagnosis, initial staging, therapy planning, early treatment response assessment, re-staging, and prognosis.

Entities:  

Keywords:  Diagnosis; Fluorodeoxyglucose (FDG); Malignant pleural mesothelioma; Positron emission tomography/computed tomography (PET/CT); Prognosis; Re-staging; Staging; Treatment response assessment

Mesh：

Substances：

Year:  2016        PMID： 27222020     DOI： 10.1007/s11604-016-0555-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN： 1867-1071            Impact factor:   2.374


  64 in total

1.  Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

Authors:  R T Heelan; V W Rusch; C B Begg; D M Panicek; J F Caravelli; C Eisen
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Prognostic value of FDG PET imaging in malignant pleural mesothelioma.

Authors:  F Bénard; D Sterman; R J Smith; L R Kaiser; S M Albelda; A Alavi
Journal:  J Nucl Med       Date:  1999-08       Impact factor: 10.057

3.  Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.

Authors:  Yoshiyuki Abe; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Yuichi Ozeki; Atsuhisa Tamura; Kazutsugu Uematsu; Hiroshi Sakai; Tomoyuki Goya; Minoru Kanazawa; Kikuo Machida
Journal:  Oncol Rep       Date:  2011-10-24       Impact factor: 3.906

4.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

5.  A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.

Authors:  V W Rusch
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

Review 6.  Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Authors:  Zhen J Wang; Gautham P Reddy; Michael B Gotway; Charles B Higgins; David M Jablons; Mohan Ramaswamy; Randall A Hawkins; W Richard Webb
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

7.  18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough.

Authors:  Elisa Roca; Sophie Laroumagne; Thomas Vandemoortele; Stéphane Berdah; Hervé Dutau; Fabien Maldonado; Philippe Astoul
Journal:  Lung Cancer       Date:  2012-12-01       Impact factor: 5.705

8.  Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  Bernard Duysinx; Delphine Nguyen; Renaud Louis; Didier Cataldo; Tarik Belhocine; Pierre Bartsch; Thierry Bury
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

9.  Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.

Authors:  Brad E Wilcox; Rathan M Subramaniam; Patrick J Peller; Gregory L Aughenbaugh; Francis C Nichols Iii; Marie Christine Aubry; James R Jett
Journal:  Clin Lung Cancer       Date:  2009-07       Impact factor: 4.785

Review 10.  Response evaluation in mesothelioma: Beyond RECIST.

Authors:  Lin Cheng; Nina Tunariu; David J Collins; Matthew D Blackledge; Angela M Riddell; Martin O Leach; Sanjay Popat; Dow-Mu Koh
Journal:  Lung Cancer       Date:  2015-08-22       Impact factor: 5.705
View more
  6 in total

Review 1.  Imaging for Response Assessment in Cancer Clinical Trials.

Authors:  Anna G Sorace; Asser A Elkassem; Samuel J Galgano; Suzanne E Lapi; Benjamin M Larimer; Savannah C Partridge; C Chad Quarles; Kirsten Reeves; Tiara S Napier; Patrick N Song; Thomas E Yankeelov; Stefanie Woodard; Andrew D Smith
Journal:  Semin Nucl Med       Date:  2020-06-10       Impact factor: 4.446

2.  Fluorodeoxyglucose versus Choline Positron Emission Tomography/Computed Tomography Response Evaluation in Two Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Neoadjuvant Chemotherapy.

Authors:  Kazuhiro Kitajima; Toru Nakamichi; Seiki Hasegawa; Kozo Kuribayashi; Koichiro Yamakado
Journal:  Cureus       Date:  2018-11-28

Review 3.  The Prognostic Value of 18F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review.

Authors:  Silvia Taralli; Romina Grazia Giancipoli; Carmelo Caldarella; Valentina Scolozzi; Sara Ricciardi; Giuseppe Cardillo; Maria Lucia Calcagni
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

Review 4.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18

5.  Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma.

Authors:  Olivia Lauk; Miriam Patella; Thomas Neuer; Bianca Battilana; Thomas Frauenfelder; Thi Dan Linh Nguyen-Kim; Walter Weder; Claudio Caviezel; Sven Hillinger; Ilhan Inci; Isabelle Opitz
Journal:  Cancer Imaging       Date:  2021-08-03       Impact factor: 3.909

6.  A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.

Authors:  Rumeng Gu; Luxi Jiang; Ting Duan; Chun Chen; Shengchang Wu; Deguang Mu
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.